Institutional surgical device liability forecasting. Solve for omega-3 coating benchmarks, revision surgery multipliers, and inflammatory risk.
MDL DATA
2026 Statutory Sync
| Metric | Verification |
|---|---|
| Litigation Venue | MDL 2753 |
| Coating Issue | Omega-3 Coating |
| Claim Volume | 3,500+ Claims |
| Injury | Avg Settlement |
|---|---|
| Revision Surgery Required | $175,000 |
| Inflammatory Reaction | $125,000 |
| Chronic Pain / Adhesions | $75,000 |
| Factor | Multiplier |
|---|---|
| Revision Surgery | 3.5x Base |
| Omega-3 Reaction | Infection Risk |
| Audit Version | S-Class v2.6 |
Hernia mesh liability is governed by **Coating Failure Protocols**. Our engine audits settlement potentials based on inflammatory reaction pathology, revision surgery necessity logs, and current 2026 MDL 2753 benchmarks.
Audit of revision surgery operative logs
Omega-3 inflammatory reaction sync
NH MDL 2753 settlement roadmap
"Calibrated against 2026 District of New Hampshire MDL filings, FDA MAUDE database reports, and hernia mesh actuarial benchmarks."
A: In 2026, settlements range from $50,000 for chronic pain to over $250,000 for cases involving severe infections or multiple revision surgeries. Total compensation depends on documented medical expenses and the extent of organ damage.
A: The primary allegation is that the proprietary omega-3 fatty acid coating (fish oil) is not biocompatible and triggers severe inflammatory responses, causing the mesh to adhere to organs or fail prematurely.
A: Yes, as of 2026, the Atrium C-Qur multidistrict litigation is active. Patients who suffered complications from C-Qur mesh products may still be eligible to join the litigation or participate in settlement programs.
Don't suffer through device failure without recourse. Initiate your official S-Class forensic hernia mesh liability audit.
INITIATE AUDIT NOW